Net sales of Swedish pharmaceutical company Recipharm fluctuated until 2012, but increased annually the following years. The highest amount was reached in 2023, at some 14.7 billion Swedish kronor. In 2024, the revenue decreased due to the spin-off of the company's inhaled and nasal drug-device business. Recipharm is a Swedish pharmaceutical contract development and manufacturing organization, founded in Stockholm in 1995.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Recipharm, & Nasdaq Nordic. (April 22, 2025). Net sales of Recipharm from 2009 to 2024 (in million SEK) [Graph]. In Statista. Retrieved May 09, 2026, from https://www.statista.com/statistics/947030/annual-revenue-of-recipharm/
Recipharm, und Nasdaq Nordic. "Net sales of Recipharm from 2009 to 2024 (in million SEK) ." Chart. April 22, 2025. Statista. Accessed May 09, 2026. https://www.statista.com/statistics/947030/annual-revenue-of-recipharm/
Recipharm, Nasdaq Nordic. (2025). Net sales of Recipharm from 2009 to 2024 (in million SEK) . Statista. Statista Inc.. Accessed: May 09, 2026. https://www.statista.com/statistics/947030/annual-revenue-of-recipharm/
Recipharm, and Nasdaq Nordic. "Net Sales of Recipharm from 2009 to 2024 (in Million Sek) ." Statista, Statista Inc., 22 Apr 2025, https://www.statista.com/statistics/947030/annual-revenue-of-recipharm/
Recipharm & Nasdaq Nordic, Net sales of Recipharm from 2009 to 2024 (in million SEK) Statista, https://www.statista.com/statistics/947030/annual-revenue-of-recipharm/ (last visited May 09, 2026)
Net sales of Recipharm from 2009 to 2024 (in million SEK) [Graph], Recipharm, & Nasdaq Nordic, April 22, 2025. [Online]. Available: https://www.statista.com/statistics/947030/annual-revenue-of-recipharm/
